Product Images Levofloxacin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Levofloxacin NDC 0409-0528 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - levofloxacin 01

Chemical Structure - levofloxacin 01

Figure 2 - levofloxacin 02

Figure 2 - levofloxacin 02

Figure 3 - levofloxacin 03

Figure 3 - levofloxacin 03

This is a graph showing the time profiles of the mean levofloxacin plasma concentration after taking a 500mg tablet orally and 500mg intravenously. The y-axis shows the plasma concentration in mcg/mL.*

Logo - levofloxacin 04

Logo - levofloxacin 04

Logo - levofloxacin 05

Logo - levofloxacin 05

PRINCIPAL DISPLAY PANEL - 50 mL Bag Label - levofloxacin 06

PRINCIPAL DISPLAY PANEL - 50 mL Bag Label - levofloxacin 06

PRINCIPAL DISPLAY PANEL - 50 mL Bag Pouch - levofloxacin 07

PRINCIPAL DISPLAY PANEL - 50 mL Bag Pouch - levofloxacin 07

Levofloxacin in 5% Dextrose Injection is a medication used for intravenous infusion with a concentration of 250 mg in 50 mL 5% Dextrose, equivalent to 5 mg/mL. It is important to leave the bag in the overwrap until use and store it at room temperature. It contains a hydrochloric acid, NF and/or sodium hydroxide, NF for pH adjustment. It should not be used in an ongoing connection and any unused portion should be discarded. It is available in a single unit, with product information including dosage and storage instructions.*

PRINCIPAL DISPLAY PANEL - 100 mL Bag Label - levofloxacin 08

PRINCIPAL DISPLAY PANEL - 100 mL Bag Label - levofloxacin 08

Levofloxacin in 5% Dextrose Injection is a single-use, nonpyrogenic container with 500 mg of levofloxacin diluted in 100 mL of 5% dextrose. It is used for intravenous infusion and must be used immediately after opening. The infusion should take 60 minutes, and no further dilution is necessary. The container should not be used in series connection or with additives infused with the same IV line. The container closure does not contain natural rubber latex. It is distributed by Hospira and contains DEHP.*

PRINCIPAL DISPLAY PANEL - 100 mL Bag Pouch - levofloxacin 09

PRINCIPAL DISPLAY PANEL - 100 mL Bag Pouch - levofloxacin 09

This is a label for Levofloxacin in 5% Dextrose Injection, which is a solution for intravenous infusion administered over 60 minutes. Each 100 mL contains a dilution solution equivalent to 500mg of Levofloxacin, along with 5% Dextrose. The dosage, storage instructions, and handling precautions are mentioned. There is also an indication that the bag should be left in the overwrap until used and that the single-use container should be discarded after use. The label also mentions the NDC number and manufacturer's information.*

PRINCIPAL DISPLAY PANEL - 150 mL Bag Label - levofloxacin 10

PRINCIPAL DISPLAY PANEL - 150 mL Bag Label - levofloxacin 10

This is a description of a medication called Levofloxacin in 5% Dextrose Injection which comes in a 150 mL container with 750 mg of the medication per 150 mL. The medication is meant to be used for intravenous infusion without further dilution. The container should be used immediately upon removal from the overwrap and should not be used in series connection. Any unused portion should be discarded after use. The medication is sterile and non-pyrogenic and should only be used if the solution is clear and the container is undamaged. The usual adult dosage is not provided in the text. The medication is distributed by Hospira, Inc. in Lake Forest, USA. The expiration date is also provided.*

PRINCIPAL DISPLAY PANEL - 150 mL Bag Pouch - levofloxacin 11

PRINCIPAL DISPLAY PANEL - 150 mL Bag Pouch - levofloxacin 11

Levofloxacin in 5% dextrose injection is a dilute solution used for intravenous infusion with a total volume of 150 mL. Its usual adult dosage is advised to be checked before use. The product must be stored at 20 to 26°C (68 to 77°F) and should not be frozen. It is a single-use container, and any unused portion should be discarded. The container does not contain natural rubber latex, and additives must not be added to the same intravenous line. It is distributed by Hospira, Inc.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.